AcelRx Pharmaceuticals Inc (ACRX) stock is down -9.17% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ACRX stock a score of 74 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 95. ACRX's rank also includes a fundamental score of 87. In addition to the average rating from Wall Street analysts, ACRX stock has a mean target price of 6. This means analysts expect the stock to increase 203.03% over the next 12 months. The short-term technical score for ACRX is 41.
What's Happening with ACRX Stock Today
AcelRx Pharmaceuticals Inc (ACRX) stock has gained 5.32% while the S&P 500 is up 1.69% as of 2:10 PM on Monday, Oct 12. ACRX is up $0.10 from the previous closing price of $1.88 on volume of 4,014,841 shares. Over the past year the S&P 500 is higher by 19.21% while ACRX is down -9.17%. ACRX lost -$0.62 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on AcelRx Pharmaceuticals Inc (ACRX) Stock.
